Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USP To Finalize Medicare Rx Model Formulary In 2004; VA System As Guide?

Executive Summary

The Veterans Affairs medication classification system is likely to serve as a starting point for the U.S. Pharmacopeia's development of a model formulary for the Medicare prescription drug benefit

You may also be interested in...



Pharmacologic Class In Label Should Be Set By Formulary, Not Industry – ASHP

A recent FDA draft guidance that leaves pharmacologic class determination in the hands of drug manufacturers has led the American Society of Health-System Pharmacists to offer its American Hospital Formulary System classification as an alternative

Pharmacologic Class In Label Should Be Set By Formulary, Not Industry – ASHP

A recent FDA draft guidance that leaves pharmacologic class determination in the hands of drug manufacturers has led the American Society of Health-System Pharmacists to offer its American Hospital Formulary System classification as an alternative

USP Medicare Formulary Design Committee To Host Public Meeting Aug. 27

The U.S. Pharmacopeia's expert committee on Medicare model guidelines will hold a public meeting Aug. 27 in Baltimore to discuss the design of the formulary template for the new outpatient prescription drug benefit

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043996

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel